Table 1.
Domain | Inclusion Criteria | Exclusion Criteria |
---|---|---|
Population | Studies with human patients of any age, gender and ethnicity who have focal chondral defects of the tibiofemoral joint. | Studies with patients who have diffuse osteoarthritis. Studies conducted on animals or cadavers. Ex vivo, in vitro and in silico studies. |
Intervention | Studies that use implants made with autologous chondrocytes or mesenchymal stem cells. Studies using cell-seeded scaffolds. |
Studies that do not use implants, intra-articular injection or cell-free scaffolds. |
Comparison | Studies that compare use of implant to cell-free therapies such as microfracture. | None |
Outcome | Studies that describe the integration between the novel and native cartilage. | Studies where the outcomes of tibiofemoral and patellofemoral defects cannot be differentiated. Studies that do not have a measuring or scoring system for integration. Studies that do not report integration separately. |
Study Type | English with full text available. Sample size greater than 10 patients. |
Case report, case series with fewer than 10 patients and review article. |